#United States #Nashville #SkinPen #Revance #Aesthetics

Revance Celebrates a Milestone in Aesthetic Treatment

Revance, a rapidly growing global player in skincare and aesthetics, recently announced an impressive milestone: the distribution of over one million SkinPen treatment kits across the United States since January 2025. This significant achievement comes shortly after the launch of their latest product, SkinPen Precision Elite, and reflects an increasing appetite for professional microneedling treatments.

A New Era for Microneedling and Aesthetics

SkinPen Precision stands as the leading brand in the U.S. microneedling market, acknowledged for setting high standards in mechanical microneedling technology, known for delivering clinically backed results while limiting downtime. The newly introduced SkinPen Precision Elite is specifically designed for enhanced balance and comfort, setting a new benchmark for consistency in treatment delivery.

"Celebrating the distribution of one million kits is not just a number; it exemplifies the burgeoning interest in microneedling as a go-to aesthetic treatment," said Nadeem Moiz, CEO of Revance. This rapid development underscores Revance’s dedication to innovation, education, and ensuring reliable results for both practitioners and clients.

Promotional Milestones

To commemorate this achievement, Revance has launched the '$100 Reasons to Love SkinPen' patient rebate initiative, which allows patients to save $100 when undergoing a series of three or more SkinPen treatments. This promotional offer runs from February 1 to June 30, 2026, aiming to boost provider engagement and patient interest in SkinPen’s effective treatment plans.

Support from the Medical Community

Medical professionals have echoed the sentiments surrounding SkinPen's impact on the industry. Dr. Rishi Chopra, a reputable authority in dermatology, remarked, "SkinPen is continuously improving the standard for professional microneedling, and this rapid growth highlights the technological advancements that are vital for both patients and providers to consider."

Looking forward, Revance plans to keep investing in the SkinPen brand, ensuring sustained growth in the microneedling category and extending its reach to attract more patients to experience the transformative skincare benefits that SkinPen delivers.

For further information about SkinPen and ongoing innovations, visit Revance and SkinPen.

Rebate Program Details

Open to U.S. residents aged 22 and older, the rebate program started on February 1, 2026, and concludes at 11:59 PM PT on June 30, 2026. To qualify, claims must be submitted by July 7, 2026, and are contingent upon the purchase of three or more SkinPen treatments from authorized providers. Only one rebate claim is permitted per individual, and the rebate will be issued in the form of a pre-paid digital gift card.

About Revance

Revance operates as a global leader in the aesthetic, skincare, and therapeutics sectors, providing innovative therapeutic treatments that appeal to a diverse clientele. With a strong mission to redefine the expectations of aesthetics and skincare through scientifically driven advancements, Revance relies on its extensive research and development efforts, coupled with the expertise of recognized industry professionals. For more insights, visit their official website.

Important Safety Information

SkinPen and SkinPen Precision Elite are specialized devices meant for treating facial acne scars and neck wrinkles in people over the age of 22. Possible side effects post-treatment include temporary redness and tenderness. Always consult a licensed provider to understand if SkinPen treatments suit your needs.